• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.90 130.70
(0.53%)
Sensex
82,147.56 705.52
( 0.87%)
Bank Nifty
55,760.85 84.00
( 0.15%)
Nifty IT
37,107.95 169.85
( 0.46%)
Global Indices
Nasdaq
42,322.33 -126.41
(-0.30%)
Dow Jones
5,957.59 -34.22
(-0.57%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,811.04 9.75
(0.11%)
Forex
USD-INR
85.85 0.27
(0.32%)
EUR-INR
97.86 0.31
(0.32%)
GBP-INR
116.24 0.53
(0.46%)
JPY-INR
0.60 0.00
(0.24%)

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541540
INE624Z01016
302.8807289
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SOLARA
0
2089.86
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Ambalal Sarabhai Enterprises reports consolidated net loss of Rs 0.27 crore in the March 2025 quarter
May 31,2025
Net loss of Ambalal Sarabhai Enterprises reported to Rs 0.27 crore in the quarter ended March 2025 as against net profit of Rs 9.02 crore during the previous quarter ended March 2024. Sales rose 19.25% to Rs 64.81 crore in the quarter ended March 2025 as against Rs 54.35 crore during the previous quarter ended March 2024.

For the full year,net profit declined 13.20% to Rs 4.93 crore in the year ended March 2025 as against Rs 5.68 crore during the previous year ended March 2024. Sales rose 13.03% to Rs 196.19 crore in the year ended March 2025 as against Rs 173.57 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales64.8154.35 19 196.19173.57 13
OPM %8.188.56 -4.122.08 -
PBDT5.978.54 -30 15.8410.23 55
PBT4.958.29 -40 11.836.65 78
NP-0.279.02 PL 4.935.68 -13